Natalie Callander is Professor of Medicine in the Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health. She serves as Director of the UW Carbone Cancer Center Myeloma Clinical Program, Vice Chair of the NCCN Myeloma Committee, and Interim Director of Bone Marrow Transplant. She is also a member of the NCI Myeloma Steering Committee and the ECOG Myeloma Committee.

Dr. Callander earned her medical degree from Tufts University School of Medicine in Boston, Massachusetts, completed her Internal Medicine residency at Bellevue Hospital, New York University in New York, and her Hematology/Oncology fellowship at the University of California San Diego Medical Center.

Her clinical and research work focuses on multiple myeloma treatment, including CAR T-cell therapy, minimal residual disease-guided therapy, and novel therapeutic combinations. She has been involved in major clinical trials including the MASTER-2 trial and investigations of BCMA-directed therapies. Dr. Callander has received three UW Health Patient Experience Physician Champion Awards, been named to the Best Doctors in America list since 2004, selected as a Madison Magazine Top Doctor three times, and received the Chuck Koval Award for Excellence in Myeloma presented by the Leukemia and Lymphoma Society.